Investors
Press Releases
Press releases issued by Palatin are accessible below. These press releases contain additional information about our business, clinical trial developments, research and development activities, financial achievements, and strategic partnerships.
Found 316 Results
Palatin Completes Enrollment in Phase 3 MELODY-1 Study of PL9643 For the Treatment of Patients with Dry Eye Disease
September 7, 2023
Palatin Announces Direct-to-Consumer Telehealth Partnership with UpScriptHealth™ for Vyleesi®
August 7, 2023
Palatin Announces Preliminary Fourth Quarter Fiscal 2023 Vyleesi® Product Revenue Results
July 11, 2023
Palatin Presents Preclinical Diabetic Nephropathy Data at the International Podocyte Conference
May 30, 2023
Palatin Reports Third Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update
May 16, 2023
Page 5 of 32